Trademark: AT THE EDGE OF IMPOSSIBLE 2118997
Word
AT THE EDGE OF IMPOSSIBLE
ID
2118997
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
19 November 2019
Registration Date
19 November 2019
Renewal Date
19 November 2029
Owner(s)
Service
WRAYS PTY LTD
Goods and Services:
Class 1:
Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human or animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human or animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes.
Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human or animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human or animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes.
Class 5:
Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human or animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes.
Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human or animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes.
Class 42:
Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of antibodies; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof.
Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of antibodies; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof.